Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2025-12-25 @ 1:40 PM
NCT ID: NCT04778592
Description: None
Frequency Threshold: 0
Time Frame: 9 weeks (up to 4 week screening period, 4 week treatment period, & 1 week follow up period)
Study: NCT04778592
Study Brief: Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ETX-018810 Drug: ETX-018810 bid ETX-018810: Study Drug 0 None 0 74 11 74 View
Placebo Matching Placebo bid Placebo: Placebo 0 None 1 74 15 74 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Colon cancer metastatic NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (23.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Abdominal discomfort NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Abdominal pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Abdominal pain upper NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Diarrhoea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Dyspepsia NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (23.0) View
Blood creatine phosphokinase increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (23.0) View
Haematocrit decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (23.0) View
SARS-CoV-2 test positive NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (23.0) View
Weight increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (23.0) View
Asthenia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (23.0) View
Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (23.0) View
Chest discomfort NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (23.0) View
Peripheral swelling NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (23.0) View
Nasopharyngitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (23.0) View
Otitis media NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (23.0) View
Hyperhidrosis NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (23.0) View
Rash NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (23.0) View
Blister NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (23.0) View
Hyperglycaemia NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (23.0) View
Dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (23.0) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (23.0) View
Lethargy NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (23.0) View
Restless legs syndrome NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (23.0) View
Sciatica NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (23.0) View
Somnolence NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (23.0) View
Hepatomegaly NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (23.0) View
Muscle spasms NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (23.0) View
Musculoskeletal stiffness NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (23.0) View
Abnormal dreams NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (23.0) View
Pulmonary mass NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (23.0) View